China To Publicize Names Of Pharma Involved In Bribery Starting In March
This article was originally published in PharmAsia News
Executive Summary
China’s Health and Family Planning Commission recently announced it will publicize the names of pharmaceutical companies involved in bribery allegations starting in March.